We have previously shown that c-Fos activates phospholipid synthesis through a mechanism independent of its genomic AP-1 activity. Herein, using PC12 cells induced to differentiate by nerve growth factor, the genomic effect of c-Fos in initiating neurite outgrowth is shown as distinct from its nongenomic effect of activating phospholipid synthesis and sustaining neurite elongation. Blocking c-Fos expression inhibited differentiation, phospholipid synthesis activation, and neuritogenesis. In cells primed to grow, blocking c-Fos expression determined neurite retraction. However, transfected cells expressing c-Fos or c-Fos deletion mutants with capacity to activate phospholipid synthesis sustain neurite outgrowth and elongation in the absence of nerve growth factor. Results disclose a dual function of c-Fos: it first releases the genomic program for differentiation and then associates to the endoplasmic reticulum and activates phospholipid synthesis. Because phospholipids are key membrane components, we hypothesize this latter phenomenon as crucial to support membrane genesis demands required for cell growth and neurite elongation.
INTRODUCTION
Relevant progress has been achieved in discerning the regulatory processes involved in the expression of genes controlling cell growth, a temporarily advanced phenomenon with respect to growth. However, how cells fulfill their demands of membrane components required for cell growth and morphological differentiation is still unclear, and progress in the comprehension of the biochemical mechanisms that coordinate bulk membrane component production in the course of cell growth remains fragmentary.
Among genes involved in the control of the cell cycle, the early response genes fos and jun have been thoroughly investigated. fos is a multigene family encoding five proteins, c-Fos, Fos-B, ⌬ Fos-B, Fra-1 and Fra-2, whereas the jun family has three members, c-Jun, JunB, and JunD (Hai and Curran, 1991; Shaulian and Karin, 2002) . Fos and Jun proteins are usually not constitutive components of cells; rather they are rapidly and transiently induced in many cell types as a response to diverse stimuli such as growth factors, sensorial stimulation, and neurotransmitters (Curran and Morgan, 1987; Hughes and Dragunow, 1995; reviewed in Caputto and Guido, 2000) . The Fos proteins cross-dimerize through leucine zipper interactions with protein products of the jun genes but do not homodimerize (Angel and Karin, 1991) . The resulting heterodimers are the highly charged, basic, DNA-binding AP-1 transcription factors. These AP-1 dimers typically affect key events of cell division and differentiation by regulating downstream target genes. Identification of the transcription factor activity of these early response genes directed outcoming research toward establishing the regulatory constraints that determine their expression and the target genes that respond to their induction (Kovary and Bravo, 1992; Lallemand et al., 1997) . There is now a considerable body of information concerning AP-1 induction pathways and expression patterns of various inducible early response genes.
On the other hand, data are fragmentary regarding the concerted metabolic response elicited in cells in response to induction of genes controlling growth. In this regard, the possibility that expression of their protein products in cytoplasm may have regulatory activities independent of, or in addition to those they exert in the nucleus had not been investigated in detail. In the present report, we examined the role of c-Fos in regulating the synthesis of phospholipids required for the genesis of membrane associated with cell growth and morphological differentiation of rat pheochromocytoma PC12 cells. Our results suggest that once the c-Fos-mediated genomic events required for neurite outgrowth have been triggered by nerve growth factor (NGF), cytoplasmic c-Fos is sufficient to sustain neurite elongation through a mechanism that involves c-Fos association to the ER and phospholipid synthesis activation.
MATERIALS AND METHODS

Cell Culture
PC12 cells were grown at 37°C in 5% CO 2 in DMEM (Sigma-Aldrich, St. Louis, MO) supplemented with 0.04 mM glutamine and 5% fetal bovine serum Article published online ahead of print. Mol. Biol. Cell 10.1091/ mbc.E03-09 -0705. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03-09 -0705. □ D Online version of this article contains supplementary material.
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(Invitrogen, Carlsbad, CA) plus 5% horse serum (Invitrogen). For establishing quiescence, cells grown for 72 h in DMEM supplemented with 5% horse serum plus 5% fetal bovine serum had their medium changed to DMEM supplemented with 1% horse serum for an additional 36 h. After this time in culture, the cells depleted the medium of serum growth factors and were growth arrested (Araki and Wurtman, 1997) . To stimulate cells to differentiate, fresh medium containing 100 ng/ml NGF (Invitrogen) replaced medium in each well. Sister control cultures received the same volume of fresh medium without NGF. For cotransfection of PC12 cells, cells were seeded onto acid-washed coverslips coated with poly-lysine (1 g/ml) in 35-mm petri dishes containing 2 ml of DMEM, and attached cells were transiently transfected with 5 g of total DNA by using FuGENE 6 transfection reagent (Roche Diagnostics, Indianapolis, IN) according to manufacturer instructions. pcDNA3Fos (4 g) (or the corresponding vector for controls) was cotransfected with 1 g of pEYFP-N1 (BD Biosciences Clontech, Palo Alto, CA) or of lip33-pEYFP (Giraudo and Maccioni, 2003) . More than 60% of the cells were pEYFP-N1 or lip33-pEYFP positive. Only these positive cells were considered for morphometric quantification of neurite formation. For establishing quiescence, transfected cells were treated as described above. For transfection with c-Fos or c-Jun antibody, 100 g/ml c-Fos (Ab4) or c-Jun (N-G) antibody, as indicated (Santa Cruz Biotechnology, Santa Cruz, CA), was delivered at the indicated time to quiescent PC12 cells with BioPORTER QuickEasy delivery kit (Sigma-Aldrich) as indicated by the manufacturer, and cells were cultured to complete 4 d. Sister control cells (mock) received the same volume of the delivery system.
In the experiments with cellular effectors such as NGF, oligonucleotides (5Ј-G S A ACA TCA TGG TCG S T-3Ј c-fos mRNA antisense oligonucleotide [ASO] and corresponding sense or random c-fos mRNA oligonucleotide [SO]) (Biosynthesis, Lewisville, TX), acetyl calpastatin (A-Calp) (Sigma-Aldrich), and a peptide carrying the AP-1 nuclear localization signal peptide (NLSP) (Biosynthesis), these were added to cultures in 5 l of medium at the times and concentrations indicated for each experiment. Sister control cells received the same volume of medium alone, or in the case of experiments with ASO, the same volume of medium containing the corresponding SO. Medium was replaced with fresh medium containing the corresponding cellular effector as indicated for each experiment at 48 and 72 h after initiation of cell treatment.
Cell Phospholipid Labeling
To determine 32 P-phospholipid labeling capacity, PC12 cells were grown as indicated above. Control and treated cells were pulsed with 45 Ci/ml 32 P i (PerkinElmer Life Sciences, Boston, MA) 2 h before harvesting.
32 P-Phospholipid labeling was determined using the trichloroacetic acid-phosphotungstic acid method described previously (Guido and Caputto, 1990) . Lipid extracts in chloroform:methanol [2:1 (vol/vol)] were dried for radioactivity quantification or used for chromatographic separation of individual phospholipids.
Immunofluorescence Analysis
Cells grown on round, acid-washed coverslips coated with poly-lysine (1 g/ml) and treated as indicated were rinsed with cool phosphate-buffered saline (PBS) and fixed for 10 min with 3% paraformaldehyde (wt/vol) plus 4% sucrose in PBS at 37°C. Cells were then permeabilized by treatment with 0.25% Triton X-100 in PBS for 10 min, washed three times with PBS, and blocked with PBS containing 1% bovine serum albumin plus Tween 20 [0.1% (vol/vol)] (blocking buffer) for 2 h at room temperature in a humid chamber. The coverslips were incubated overnight at 4°C with blocking buffer containing a polyclonal antibody to c-Fos (Ab4 or antibody 125, as indicated; Santa Cruz Biotechnology) and/or a polyclonal antibody to calnexin (Santa Cruz Biotechnology) for endoplasmic reticulum (ER) immunolabeling and/or a monoclonal antibody to ␣-tubulin (␣-Tub) (DM1-A; Sigma-Aldrich). For viable cells transfected and cultured for 4 d with c-Fos or c-Jun antibody, only ␣-tubulin (DM1-A) or calnexin antibodies were present in the blocking buffer; c-Fos or c-Jun antibodies were omitted because they were previously transfected into the cells. Cells were washed with PBS plus Tween 20 [0.1% (vol/vol)] and then incubated for 2 h at room temperature in blocking buffer in a humid chamber with Alexa 546 and/or Alexa 488 and/or phalloidin red (Molecular Probes, Eugene, OR) as necessary. Coverslips were washed, mounted in Prolong Antifade (Molecular Probes), and visualized on a confocal laser scanning microscope LSM 510 (Carl Zeiss, Thornwood, NY) by using LSM 510 software for image analysis. When was necessary tetramethylrhodamine B isothiocyanate-conjugated anti-rabbit IgG and fluorescein isothiocyanate-conjugated anti-mouse IgG (Santa Cruz Biotechnology) was used for each case, mounted as described above, and then observed on an Axioplan epifluorescence microscope (Carl Zeiss) equipped with a Princeton Instrument Micromax camera controlled with MetaMorph Imaging software (Universal Imaging, Downingtown, PA).
Expression and Purification of c-Fos and c-Jun FullLength and Deletion Mutants
c-Fos and c-Jun full-length and c-Fos deletion polypeptides containing the indicated amino acids were synthesized as histidine-tagged proteins in Escherichia coli as described previously . The additional truncated genes were constructed from full-length c-Fos cDNA (a gift of T. Curran, St. Jude Childrens Hospital, Memphis, TN) with oligonucleotides corresponding to the 5Ј and 3Ј ends of the coding sequence to be amplified, cloned in pGEM-T-easy (Promega), and then subcloned in the prokaryote expression vector pET15b (Novagen) by using the NdeI and EcoR1 sites of the polylinker sequence of the vector. The hexahistidine-tagged proteins were synthesized in E. coli and purified from cell lysates by nickel affinity chromatography by running through HisBin resin (Novagen, Madison, WI).
For PC12 cell transfections, the pcDNA 3.1 eukaryotic expression vector containing the coding sequence of the corresponding deletion polypeptide obtained from the full length c-Fos dDNA (kindly supplied by J. Blenis, Harvard Medical School, Boston, MA) inserted in the EcoR1 site of the polylinker sequence of the vector was used.
Morphometric Analysis
To determine number of neurites per cell or length of neurites present in individual cells, antibody-labeled, Prolong Antifade-mounted coverslips were examined under epifluorescence microscope with filters adjusted for visualization of the antibody against ␣-Tub, by using the Morphometric menu of the MetaMorph Imaging software. For statistical purposes, double-blind quantification was performed as follows: 1) a cell prolongation was considered a neurite when its length was at least the diameter of the cell body; 2) when neurites were branched, only the longest ramification was considered to establish the total length of the neurite; 3) when a given cell had two or more neurites, only the longest neurite was considered; and 4) calculation of percentage of cells with neurites was only for viable cells. Consequently, differences between neurite-bearing and neurite-devoid cells are usually larger than those reflected in the final numbers of the figures. At least 300 cells for a given experimental condition were examined.
Protein Analysis
Cells were harvested in Protease Inhibitor Cocktail (Sigma-Aldrich); SDS-PAGE and Western blotting were performed as described previously (Bussolino et al., 2001 ) by using anti c-Fos polyclonal antibody (Santa Cruz Biotechnology). Immunoreactive bands were detected as described by Nakane (1968) with protein A-conjugated peroxidase (Sigma-Aldrich) or by ECL Plus (Amersham Biosciences, Piscataway, NJ) by using biotinylated antibodies (Vector Laboratories, Burlingame, CA) and streptavidin-horseradish peroxidase conjugate (Amersham Biosciences).
In Vitro Labeling of Phospholipids
In vitro phospholipid labeling capacity of PC12 cells was assayed by incubation for 60 min at 37°C in medium containing, in a final volume of 80 l, 140 mM NaCl, 4.5 mM KCl, 0.5 mM MgCl 2 , 5.6 mM glucose, HEPES buffer, pH 7.4, 64 mM, 3 Ci of [ 32 P]ATP (specific activity 3000 Ci/mmol; PerkinElmer Life Sciences), and indicated amounts of c-Fos or c-Jun protein suspended in 3 l of 300 mM imidazole/8 M urea. Control incubates contained only 3 l of 300 mM imidazole/8 M urea. Reactions were initiated by addition of 300 g of PC12 cell homogenate and stopped by addition of TCA-PTA (5-0.5% respectively, final concentration). Phospholipid labeling was quantified by the TCA-PTA method (Guido and Caputto, 1990) . For assays in the absence of nuclear fraction, PC12 homogenates were fractionated according to Neri et al. (1998) . Nucleus contamination in homogenates devoid of nuclei was monitored by dot blot in final preparations by using an anti-Histone 1 antibody (Santa Cruz Biotechnology). Contamination was Ͻ5% of the DNA present in the starting homogenates.
Statistics
Statistical analysis of all morphometric quantifications was performed by one-way analysis of variance (ANOVA) with Newman-Keuls post hoc tests, when appropriate. Statistical analysis of radiolabeled phospholipids was performed by two-tailed Student's t test.
RESULTS
Nuclear and Cytoplasmic c-Fos Are Required at Different
Stages of Cell Differentiation and Growth PC12 cells were examined for c-Fos immunocytochemical expression and subcellular localization at 5 and 60 min after feeding NGF ( Figure 1A ). Coimmunostaining for ␣-Tub served to delineate the cell body and neurites. No c-Fos immunostaining was observed at zero time of NGF treatment but by 5 min, NGF induced early and significant expression of c-Fos in the cytoplasm. After 60 min, c-Fos was detected both in the cytoplasm and the nucleus. Figure 1B shows that the nuclear and cytoplasmic distribution was maintained at longer periods of NGF treatment (2 and 4 d in culture). As already reported (Greene and Tischler, 1976; Araki and Wurtman, 1997) after 2 d in culture with NGF ( Figure 1B , middle row), c-Fos expression is induced (Greenberg et al., 1985; Kruijer et al., 1985) , and cells developed toward a sympathetic-neuron-like phenotype, which was fully attained at ϳ4 d ( Figure 1B , bottom row). This process was absolutely dependent on the presence of NGF ( Figure  1B 
c-Fos Is Imported into the Cell Nucleus before Triggering Neuritogenesis
To assess the importance of the early cytoplasmic c-Fos expression on NGF-mediated PC12 neurite outgrowth shown in Figure 1B , cells were fed NGF in the presence of the NLSP AAVALLPAVLLALLAPVQRK RQKLMP (Torgerson et al., 1998) . This peptide, which carries the AP-1 signal-dependent nuclear import sequence (underlined) preceded by a cell-permeable sequence to deliver the functional domain (Lin et al., 1995) , blocks the nuclear import of c-Fos as an AP-1 dimer (Torgerson et al., 1998; . In fact, a time course of the effects of NLSP addition showed that after priming cells during 4 h with NGF, these can be fed NLSP and neurite elongation proceeds at the same rate as in cells cultured in the absence of NLSP (see Figure 1S of Supplementary Material). These results indicate that nuclear AP-1-c-Fos is required to trigger neuritogenesis at early stages of differentiation but not at later stages of neurite elongation.
Cytoplasmic c-Fos Is Required for Differentiation to Proceed
To examine whether cytoplasmic c-Fos is necessary for sustaining neurite growth, c-Fos expression was specifically impaired at different stages of NGF-induced differentiation by feeding cells the c-fos mRNA antisense oligonucleotide ASO. When cells were fed ASO at the initiation of NGF treatment, they extended no or short neurites ( Figure 3A In addition, no neurite elongation was observed after 4 d in culture when cells primed to grow by treatment with NGF during 16 h were then fed NLSP ϩ ASO ( Figure 3C , bottom row). These results, in combination with those of Figure 1C in which neurite elongation was observed after the differentiation program was triggered and cells were fed NLSP, support that cytoplasmic c-Fos is required to sustain neurite elongation.
In every experiment in which ASO was used, controls were performed with sister cultures that received an equivalent amount of SO. No differences were observed between these cultures and those in the absence of SO, either in the number of cells, the cellular content of c-Fos or in cell growth as determined by immunocytochemical examination and morphometric quantification ( Figure 3A 1.5, n ϭ 1090 for ASO-treated cells and 99.3 Ϯ 0.8, n ϭ 1045 for NGF-treated cells).
Increasing Cellular Content of c-Fos Stimulates Neuritogenesis
To further investigate the dependence of neuritogenesis on c-Fos expression, PC12 cells were treated with A-Calp, an inhibitor of calpain-dependent, cytoplasmic c-Fos degradation (Pariat et al., 2000) . c-Fos content increased in NGF ϩ A-Calp-treated cells at 4 d in culture ( Figure 2G ) with respect to cells grown with NGF alone ( Figure 2D ). Under these experimental conditions, the amount of cells extending neurites increased to near 95%, the neurites were 42% longer and the mean number of neurites per cell was 66% higher compared with cells grown in NGF alone (compare middle and top rows of Figure 4) .
The stimulating effect of A-Calp was dependent on c-Fos expression because it was abrogated upon the simultaneous treatment of cells with ASO ϩ A-Calp ϩ NGF (Figure 4, bottom row) . A-Calp or ASO alone (ϪNGF) had no effect on c-Fos expression or neuritogenesis (our unpublished data). Figure 5A , top row; Figure 10B , lane d). Morphometric quantification showed a Ͼ50% increase in neurite number and a Ͼ80% increase in neurite length ( Figure  5B , top row) in c-Fos-overexpressing cells compared with mock-transfected cells treated the 4 d with NGF ( Figure  5A , top row). If medium replacement at 16 h contained ASO, cells failed to grow ( Figure 5B , middle row) as occurred in c-Fos-transfected cells ( Figure 5A , bottom row) or in mock-transfected cells (our unpublished data) when not primed for 16 h with NGF to trigger neuritogenesis. SO had no effect on neurite elongation in the c-Fos-overexpressing cells primed to grow with NGF ( Figure 5B, bottom row) . These results indicate that once the nuclear program for cell differentiation has been triggered by NGF priming, cytoplasmic c-Fos is capable of sustaining neurite elongation.
Activation of Phospholipid Synthesis Is Associated with Cell Growth
We have previously shown that c-Fos activates phospholipid synthesis in several cell types (Guido et al., 1996; Bussolino et al., 1998 Bussolino et al., , 2001 ). To know whether phospholipid synthesis activation occurs in conditions of c-Fos-mediated neurite elongation, the 32 P-labeling of phospholipids was determined in cells at 4 d in culture in the presence or the absence of NGF. A 2.5-fold activation of 32 P-phospholipid synthesis was observed in NGF-treated cells (Figure 6 ) in accordance with previous results (Akari and Wurtman, 1997; Carter et at., 2003) . This activation was dependent on c-Fos expression because it was specifically abolished in a dose-dependent manner by the addition of ASO. By contrast, A-Calp significantly increased phospholipid labeling ϳ3.2-fold relative to cells treated with NGF alone. Blocking c-Fos import into the nucleus by feeding cells with NLSP 16 h after initiation of NGF treatment did not modify NGFactivation of 32 P-phospholipid synthesis. The continuous presence of NGF was necessary for phospholipid activation because withdrawal of NGF after 2 d of culture with NGF abrogated the activation of phospholipid synthesis measured at day 4 ( Figure 6 ). Because conditions that increase or decrease phospholipid synthesis activation also increase or decrease neurite elongation, results of Figure 6 are compatible with a phospholipid synthesis activation phenomenon participating in the c-Fos-regulated neurite elongation shown in Figures 3 and 4 .
All individual phospholipid species showed essentially the same activated 32 P-labeling in NGF-treated compared with control (ϪNGF) cells at 4 d, whereas treatment of cells with increasing concentrations of ASO promoted a general decrease in labeling of all phospholipid species (our unpublished data). (Figure 7) . Recombinant c-Fos activates phospholipid synthesis in a concentration-dependent manner, with maximal activation at 1 ng/g homogenate protein which corresponds to a concentration of ϳ10 5 molecules of c-Fos/cell. This c-Fos concentration is comparable with that calculated by Kovary and Bravo (1992) to be present in fibroblasts when c-Fos expression is induced (10 3 -10 5 molecules of c-Fos/cell). c-Fos has the same ability to activate phospholipid synthesis in vitro in total cell homogenates and in homogenates devoid of nuclei, further indicating that this activation is a cytoplasmic event ( Figure 7A ). By contrast, c-Jun, the common partner of c-Fos in AP-1 transcription factor complexes (Angel and Karin, 1991) had no effect on phospholipid synthesis when assayed in vitro at the same concentration ( Figure 7A ) or at concentrations up to threefold higher than c-Fos (our unpublished data).
c-Fos Deletion Mutants Activate Phospholipid Synthesis, Providing They Contain the Basic Domain Corresponding to Amino Acids 139 -159 of Full-Length c-Fos
To advance in the knowledge of the molecular constraints to the activating capacity of c-Fos on phospholipid synthesis, diverse c-Fos deletion mutants ( Figure 7B , left) were tested in vitro for their capacity to activate phospholipid synthesis. It was found that all mutants containing the basic domain of c-Fos (aa 139 -159) were capable of activating phospholipid synthesis in vitro when tested at 1 ng g PC12 cell homogenate protein ( Figure 7B ). Moreover, a 20-aa peptide containing only this basic domain was able to activate phospholipid synthesis to comparable levels as full-length c-Fos. Mutants containing either the first 139 aa (NA) or the last 215 aa (LZC), which includes the leucine zipper (LZ) domain required for c-Fos heterodimerization in AP-1 formation but lacks the basic domain, failed to activate phospholipid synthesis ( Figure  7B ), even when tested at a concentration range of up to 3 ng/g cell homogenate (our unpublished data).
Transfected c-Fos Deletion Mutants That Activate Phospholipid Synthesis In Vitro, Associate to the ER and Support Neurite Elongation in the Absence of NGF
To further investigate the relationship between c-Fos-mediated phospholipid synthesis and neurite elongation, this process was examined in PC12 transfected to constitutively overexpress c-Fos or its deletion mutants. Cells were cotransfected with lip33 fused to the YFP to delineate the ER (Giraudo and Maccioni, 2003) . lip33 is a type II membrane protein that contains an ER retention signal consisting of three R residues at positions 3-5 in its exposed cytoplasmic N-terminal domain (Schutze et al., 1994) . The experimental protocol followed was as in Figure 5 Comparison of immunostaining of c-Fos or its mutants with lip33-YFP as an ER marker showed abundant immunostaining in the perikarya with no detectable nuclear immunostaining. In addition, when immunostaining for c-Fos or its mutants was merged with lip33-YFP fluorescence, abundant colocalization was found only for c-Fos and for the deletion mutants NBD and NLZ (Figure 8, right) , mutants that also sustain neurite elongation. These results are in line with our hypothesis that c-Fos and its deletion mutants associate to the ER and activate phospholipid synthesis to sustain neurite elongation in cells primed to grow.
To obtain a better understanding of the c-Fos-mediated neurite elongation phenomenon, cells were fed a lipid-mediated delivery system (Zelphati et al., 2001) to introduce c-Fos or c-Jun antibody into the PC12 cells at different times of NGF treatment. As can be observed in Figure 9 , both c-Fos and c-Jun antibodies completely blocked neurite formation after 4 d in culture when delivered to the cells at 0 h, together with NGF ( Figure 9A , second and third rows) supporting that dimeric AP-1 c-Fos and c-Jun are required to trigger neuritogenesis. However, if the antibody was delivered to cells after 2 d in culture in the presence of NGF, c-Fos antibody blocked neurite extension and preformed neurites retracted ( Figure 9A , fourth row), whereas c-Jun antibody was without effect ( Figure 9A, bottom row) . Furthermore, by immunocytochemical examination of cells containing the c-Fos antibody, c-Fos protein was not found colocalizing with the ER (Figure 9B, bottom row) . These results support our hypothesis that nuclear-dimeric c-Fos is required to trigger neuritogenesis, whereas cytoplasmic c-Fos associates to the ER and sustains neurite elongation.
To further examine possible c-Fos/ER association in PC12 cells after 4 d with NGF, subcellular localization of c-Fos immunostaining was compared with immunostaining for ␣-Tub (Figure 10 , top row), with phalloidin-stained actin (Figure 9 , middle row), and with calnexin immunostaining for the ER (Figure 10, bottom row) . Confocal microscopy showed, in addition to nuclear c-Fos, abundant c-Fos immunostaining in the cell perikarya (Figure 10, top row) . In the growth cone, c-Fos immunostaining advances on the lamellipodia-localized actin filaments although at a much lower concentration than that observed for ␣-Tub-labeled neurites ( Figure 10 , middle row). In addition, abundant colocalization of c-Fos and ER immunostaining were observed in the cell body and in neurites (Figure 10 , bottom row) consistent with results of Figure 8 showing colocalization of c-Fos immunostaining with lip33-YFP and with previous results in NIH 3T3 fibroblasts (Bussolino et al., 2001) .
Only the Deletion Mutants That Sustain Growth in Primed Cells Activate Phospholipid Synthesis
To confirm that c-Fos-dependent phospholipid synthesis activation is linked to the growth process, 32 P-phospholipid synthesis was examined in cultures of transfected cells overexpressing c-Fos or expressing its deletion mutants and compared with mock-transfected cells. Figure 11A shows that full-length c-Fos and those deletion mutants that sustain growth are the only proteins capable of activating phospholipid synthesis in culture, i.e., those containing the 139 -159 basic domain, activate phospholipid synthesis in cells primed to grow ( Figure 11A, lanes g and h) . Deletion mutants not containing the basic domain do not activate either phospholipid synthesis in vitro ( Figure 7B ) or in culture ( Figure 11A , lanes f and i), and they cannot sustain neurite elongation in primed cells (Figure 8 ).
DISCUSSION
The c-Fos-containing heterodimer AP-1 was among the first inducible transcription factors identified. However, the physiological functions of c-Fos are still being unraveled (Curran and Morgan, 1987; Angel and Karin, 1991; Shaulian and Karin, 2002) . c-Fos, as an AP-1 protein, was originally thought to be involved in transducing short-term mitogenpromoting signals into longer lived changes by regulating the expression of target genes important for proliferation. Later studies also implicated AP-1 dimers, and consequently c-Fos, in growth, differentiation, and apoptosis (Smeyne et al., 1993; Shaulian and Karin, 2002) . However, the growing understanding of the multiple and complex genomic events in which c-Fos participates underscores our lack of knowledge of the precise role of AP-1, and more specifically, of c-Fos. Attempts have been made to elucidate the role of c-Fos through blocking its function by diverse in vivo and in culture experimental strategies that ranged from antisense constructs (Holt et al., 1986; Mercola et al., 1987 Mercola et al., , 1988 Nishikura and Murray, 1987; Edwards et al., 1988; Levi and Ozato, 1988; Ledwith et al., 1990) , ribozyme-mediated c-fos mRNA cleavage (Scanlon et al., 1991) , and nonfunctional heterodimers (Okuno et al., 1991) to c-fos(Ϫ/Ϫ) knockout mice (Johnson et al., 1992) . Data from these experiments generally indicated that absence of c-Fos slows or inhibits cell growth (Johnson et al., 1992) .
Results of the present study are not only consistent with the participation of c-Fos in triggering the genomic program for differentiation but also disclosed a participation of cytoplasmic c-Fos in sustaining growth by up-regulating the synthesis of phospholipids, the quantitatively most important components of all cell membranes. At the beginning of NGF-treatment of PC12 cells, it is critical that c-Fos reaches its nuclear localization to initiate the differentiation program: in cells in which nuclear import of AP-1-c-Fos was blocked at the initiation of NGF treatment, no differentiation occurred ( Figure 1C ). This differentiation activity of c-Fos is most probably related to its conventional transcription factor activity because the importin that the NLSP-peptide blocks, recognizes the bipartite nuclear localization signal formed in the AP-1 dimeric form of c-Fos rather than its monomeric form (Torgerson et al., 1998) . In addition, an antibody blocking c-Jun also blocks the differentiation process. Furthermore, cytoplasmic c-Fos is unable to compensate its early genomic effect in cell differentiation. Likewise, because neurite extension occurs whenever cytoplasmic cFos expression occurs, blocking nuclear import of c-Fos once neurite growth has been initiated by priming cells with NGF has no significant effect on neurite elongation ( Figure 1C ). However, a decrease in cytoplasmic c-Fos by blocking its synthesis with ASO or by placing cells in a culture medium free of NGF, results in neurites that not only stop growing but also retract ( Figure 3C ). Furthermore, hampering the association of c-Fos to the ER with a specific antibody has an effect comparable to that of decreasing its expression in the cytoplasm (Figure 9 ).
In view of the above-mentioned considerations, it seems reasonable to expect that once a cell is primed to grow, in this case by NGF, growth, in terms of number and extension of neurites, will be significantly slowed down if any step of the c-Fos induction pathway is impaired, or accelerated if c-fos expression is exacerbated. Two lines of experiments support the dependence of growth on c-Fos levels: one in which cellular content of c-Fos is increased either by transfecting cells to constitutively express c-Fos ( Figure 5B Results are the mean Ϯ SEM of five experiments performed in triplicate. *p Ͻ 0.0001 with respect to the corresponding control assayed in the absence of recombinant protein, as determined by Student's t test. The deletion mutants (Abate et al., 1991) are named according to the schematic drawings to the left: LZ, consists of a heptad repeat of leucines that align on one face of an ␣-helix forming a dimerization interface required to form a bimolecular DNA-binding domain; A, corresponds to a region rich in praline residues; D, a region rich in acidic residues, mainly aspartic acid; C, C terminus; N, N terminus; AD, acidic domain containing four glutamic acid residues; BD, basic domain containing 12 basic amino acids, mostly arginine residues, and forms the bimolecular DNA-binding domain upon heterodimerization. Amino acids comprised in each mutant are depicted on the far left.
c-Fos Activated Phospholipid Synthesis this hypothesis: deletion mutants lacking the leucine zipper domain required for heterodimerization and consequently for nuclear AP-1 localization retain both their phospholipid synthesis-activating capacity ( Figure 7B ) and their capacity to sustain growth in the absence of NGF in cells primed to grow, provided they contain the basic domain present amino acids 139 -159 of full-length c-Fos (Figure 8) . Moreover, these mutants associate to the ER, whereas those not containing this basic domain were not found associated with the ER after confocal microscopy examination (Figure 8 ). In view of the fact that c-Fos does not form homodimers (Angel and Karin, 1991) and that the sole addition of recombinant c-Fos or its deletion mutants containing the basic 139 -159 aa domain can reproduce the activation of phospholipid synthesis in vitro, we also conclude that c-Fos associates with ER membranes and activates phospholipid synthesis in its monomeric form. This is further sustained by the finding that in cells primed to grow, blocking c-Fos with a specific antibody completely blocks neurite extension, whereas blocking c-Jun, an immediate early gene that can form homodimeric AP-1 transcription factors, has no effect on neurite elongation (Figure 9 ). However, these results do not discard the possibility that domains of the c-Fos protein other than the basic domain may be important in establishing, for example, the ER/c-Fos association. In addition, cFos-mediated genomic events such as the recently reported increase in the mRNA of the rate limiting enzyme in phosphatidylcholine formation, CTP:phosphocholine cytidylyl transferase ␤2 (Carter et al., 2003) may also contribute to phospholipid synthesis activation.
The phenomenon of cell growth is very complex and stringent control mechanisms must operate to coordinate the production of the different cellular components in synchrony both with cell cycle and with differentiation events. Having a few proteins participating in the growth process at different subcellular sites seems a reasonable mechanism to facilitate this coordination. The very precise control mechanisms that regulate c-fos expression may ensure that a cell will trigger its nuclear growth program and will support growth by activating the production of the cellular components it requires. It is important to note that c-Fos expression is not a required factor but an activator for phospholipid synthesis; abolition of c-Fos expression in vivo does not inhibit phospholipid synthesis; it only slows down the rate of production of these lipids (Guido et al., 1996; deArriba Zerpa et al., 1999; Bussolino et al., 1999) . In accordance, c-fos(Ϫ/Ϫ) knockout mice are not lethal; these animals merely grow more slowly than their wild-type or heterozygous littermates (Johnson et al., 1992) .
Elongation of neurites requires a constant supply of plasma membrane components and its insertion into the growing tip of the neurite. The common perception that phospholipids are synthesized in the cell body and that assembled membranes organized as vesicles are then distributed to their insertion sites has been revised after it was reported that significant phospholipid synthesis occurs in the growing axon, in addition to that occurring in the soma (Vance et al., 1991 (Vance et al., , 1994 . In the present study, confocal microscopy shows colocalization of c-Fos and ER immunolabeling both in the cell body and in neurites. This points to a possible direct effect of c-Fos on the ER and opens the possibility that the diverse subcellular sites of phospholipid synthesis be regulated by c-Fos.
c-Fos activation of phospholipid synthesis is not peculiar to PC12 cells. It reflects a physiological regulatory phenomenon that has been observed in vivo in retinal ganglion (Guido et al., 1996) and photoreceptor cells (Bussolino et al., 1999) and in culture in NIH 3T3 fibroblasts (Bussolino et al., 2001) . This cytoplasmic regulatory role of c-Fos is not the only AP-1-independent activity of an early response gene. c-Jun was shown to effectively protect PC12 cells from apoptosis by an unconventional mechanism that is also separable from its well-known AP-1 activity (Leppa et al., 2001) . Future research is expected to reveal an increasingly complex but more coordinated mechanism through which all the players of cell proliferation, growth, differentiation, and death act in synchrony with one another. In addition to the multiple functions of a single induced protein, another key issue in cell growth is how signaling pathways common to many systems integrate signals from molecules having a wide spectrum of activities to deliver distinct and specific biological outcomes (Murphy et al., 2002; Vaudry et al., 2002) . Improved understanding of the molecular mechanisms involved in cell growth regulation will open the possibility of beneficially intervening in selective normal and pathological growth processes such as those occurring in transformed cells.
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